Atropine sulfate 0.06 mg / benzoic acid 9 mg / hyoscyamine sulfate 0.06 mg / methenamine 81.6 mg / methylene blue 10.8 mg / phenyl salicylate 36.2 mg Delayed Release Oral Tablet [Uritact]
RxNorm 1293461

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 1293461 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: atropine sulfate 0.06 mg / benzoic acid 9 mg / hyoscyamine sulfate 0.06 mg / methenamine 81.6 mg / methylene blue 10.8 mg / phenyl salicylate 36.2 mg Delayed Release Oral Tablet [Uritact].

The following semantic concepts and normalized strings are associated with this clinical entity:

SBD
Atropine sulfate 0.06 mg / benzoic acid 9 mg / hyoscyamine sulfate 0.06 mg / methenamine 81.6 mg / methylene blue 10.8 mg / phenyl salicylate 36.2 mg Delayed Release Oral Tablet [Uritact]
AUI:12369276
SY
Uritact EC (atropine sulfate 0.06 mg / benzoic acid 9 mg / hyoscyamine sulfate 0.06 mg / methenamine 81.6 mg / methylene blue 10.8 mg / phenyl salicylate 36.2 mg) Delayed Release Oral Tablet
AUI:6338243

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SBD

Semantic Branded Drug (SBD):
Atropine sulfate 0.06 mg / benzoic acid 9 mg / hyoscyamine sulfate 0.06 mg / methenamine 81.6 mg / methylene blue 10.8 mg / phenyl salicylate 36.2 mg Delayed Release Oral Tablet [Uritact]
(Atom ID: 12369276)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
atropine sulfate 0.06 MG / benzoic acid 9 MG / hyoscyamine sulfate 0.06 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG Delayed Release Oral Tablet [Uritact]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1293461
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12369276
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SBD
Semantic Branded Drug (Ingredient + Strength + Dose Form + Brand Name)
Source Code
1293461
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN AI
{340422} 6832
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{340423} 36122
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{346120} 18989
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{384913} 6878
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM
{340422} 6832
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{340423} 36122
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{346120} 70589
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{384913} 6878
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{340422} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{340423} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{346120} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{384913} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN OBSOLETED
04/30/2020
Date the RxNorm atom became obsolete

SY

Synonym (SY):
Uritact EC (atropine sulfate 0.06 mg / benzoic acid 9 mg / hyoscyamine sulfate 0.06 mg / methenamine 81.6 mg / methylene blue 10.8 mg / phenyl salicylate 36.2 mg) Delayed Release Oral Tablet
(Atom ID: 6338243)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Uritact EC (atropine sulfate 0.06 MG / benzoic acid 9 MG / hyoscyamine sulfate 0.06 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG) Delayed Release Oral Tablet
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1293461
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
6338243
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
1293461
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.